CARBAGLU

Drug RECORDATI_RARE_DISEASES_INC.
Total Payments
$233,904
Transactions
96
Doctors
67
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $151,972 18 0
2023 $665.75 11 10
2022 $81,267 67 57

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $151,972 18 65.0%
Grant $80,000 1 34.2%
Food and Beverage $1,932 77 0.8%

Payments by Type

Research
$151,972
18 transactions
General
$81,932
78 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
An Observational Study of Carbaglu for the Treatment of MMA and PA in Adults and Pediatrics RECORDATI_RARE_DISEASES_INC. $151,972 0

Top Doctors Receiving Payments for CARBAGLU

Doctor Specialty Location Total Records
Unknown Northbrook, IL $151,972 18
, MD Clinical Genetics (M.D.) Washington, DC $80,000 1
, MD Ophthalmology Marshalltown, IA $140.91 2
, MD DM Pediatric Nephrology Jackson, MS $88.24 1
, DO Nephrology Cordova, TN $88.24 1
, MD Nephrology Richmond, VA $88.24 1
, MD Pediatric Nephrology Jackson, MS $88.24 1
, M.D Nephrology Shreveport, LA $88.24 1
Jing Liu Gerontology Orlando, FL $80.66 4
, MD Nephrology Orlando, FL $63.35 3
, MD Nephrology Orlando, FL $60.78 3
, M.D Nephrology Orlando, FL $60.78 3
, M.D Nephrology Orlando, FL $37.19 2
, M.D Nephrology Edgewood, KY $24.27 1
, M.D Nephrology Cincinnati, OH $24.27 1
, MBBS Pediatric Nephrology Augusta, GA $23.92 1
, MD Pediatric Nephrology Augusta, GA $23.92 1
, M.D Student in an Organized Health Care Education/Training Program Augusta, GA $23.92 1
, DO Medical Oncology Stuart, FL $22.31 1
, FNP-BC Nurse Practitioner West Palm Beach, FL $22.31 1
, M.D Hematology & Oncology Lake Worth, FL $22.30 1
, MD Pediatrics Philadelphia, PA $21.88 1
, MD Pediatric Nephrology Philadelphia, PA $21.88 1
, MD Ophthalmology Miami, FL $20.98 1
, M.D Ophthalmology Irvine, CA $20.91 1

About CARBAGLU

CARBAGLU is a drug associated with $233,904 in payments to 67 healthcare providers, recorded across 96 transactions in the CMS Open Payments database. The primary manufacturer is RECORDATI_RARE_DISEASES_INC..

Payment data is available from 2022 to 2024. In 2024, $151,972 was paid across 18 transactions to 0 doctors.

The most common payment nature for CARBAGLU is "Unspecified" ($151,972, 65.0% of total).

CARBAGLU is associated with 1 research study, including "An Observational Study of Carbaglu for the Treatment of MMA and PA in Adults and Pediatrics" ($151,972).